Adoptive Immunotherapy With Cord Blood Following Chemotherapy for Refractory Myeloid Malignancies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adoptive Immunotherapy With CB Following Chemotherapy for Patients With Refractory Myeloid Malignancy: Chimerism and Response
Blood Adv 2020 Oct 27;4(20)5146-5156, OK Chaekal, A Scaradavou, E Masson Frenet, MS Albano, M Cushing, P Desai, L Dobrila, U Gergis, D Guarneri, JM Hsu, S Lee, SA Mayer, AA Phillips, N Orfali, EK Ritchie, GJ Roboz, C Romeo, MS Samuel, T Shore, K van BesienFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.